{"success":true,"data":{"pressRelease":{"id":"112243","rtpr_id":"nPn1JXJj1a","ticker":"CRNX","exchange":"NASDAQ","all_tickers":["CRNX","PSBQ","UTZ","VEEE"],"title":"SHAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger--CRNX, PSBQ, UTZ, and VEEE","author":"PR Newswire","published_at":"2026-08-06T20:33:00.250Z","article_body":"SHAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger--CRNX, PSBQ, UTZ, and VEEE\n\nPR Newswire\n\nNEW YORK, Aug. 6, 2026\n\nNEW YORK, Aug. 6, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4747555-1&h=2348939473&u=https%3A%2F%2Fprofiles.superlawyers.com%2Fnew-york%2Fnew-york%2Flawyer%2Fjuan-e-monteverde%2Fb861d99b-d20f-4376-92c4-2996390bacbc.html&a=Juan+Monteverde)\nwith Monteverde & Associates PC\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4747555-1&h=4135774098&u=http%3A%2F%2Fwww.monteverdelaw.com%2F&a=Monteverde+%26+Associates+PC)\n (the \"M&A Class Action Firm\"), has recovered millions of dollars for\nshareholders and is recognized as a Top 50 Firm in the 2025 ISS Securities\nClass Action Services Report. We are headquartered at the Empire State\nBuilding in New York City and are investigating\n\n * Crinetics Pharmaceuticals, Inc. (NASDAQ:\nCRNX\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4747555-1&h=2432464138&u=https%3A%2F%2Ffinance.yahoo.com%2Fquote%2FCRNX%2F&a=CRNX)\n\n) related to its sale to Vertex Pharmaceuticals Incorporated. Under the terms\nof the proposed transaction, Crinetics shareholders are expected to receive\n$85.00 per share in cash.\nACT NOW. The Shareholder Vote is scheduled for August 28, 2026.\n\nClick here for more info\nhttps://monteverdelaw.com/case/crinetics-pharmaceuticals-inc/\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4747555-1&h=738812358&u=https%3A%2F%2Fmonteverdelaw.com%2Fcase%2Fcrinetics-pharmaceuticals-inc%2F&a=https%3A%2F%2Fmonteverdelaw.com%2Fcase%2Fcrinetics-pharmaceuticals-inc%2F)\n. It is free and there is no cost or obligation to you.\n\n * PSB Holdings, Inc. (OTCQX:\nPSBQ\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4747555-1&h=1553703844&u=https%3A%2F%2Ffinance.yahoo.com%2Fquote%2FPSBQ%2F&a=PSBQ)\n\n) related to its sale to Bank First Corporation. Under the terms of the\nproposed transaction, PSB shareholders are expected to receive 0.3470 shares\nof Bank First common stock for each share of PSB.\nACT NOW. The Shareholder Vote is scheduled for September 2, 2026.\n\nClick here for more information\nhttps://monteverdelaw.com/case/psb-holdings-inc/\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4747555-1&h=3029835518&u=https%3A%2F%2Fmonteverdelaw.com%2Fcase%2Fpsb-holdings-inc%2F&a=https%3A%2F%2Fmonteverdelaw.com%2Fcase%2Fpsb-holdings-inc%2F)\n. It is free and there is no cost or obligation to you.\n\n * Utz Brands, Inc. (NYSE:\nUTZ\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4747555-1&h=609293463&u=https%3A%2F%2Ffinance.yahoo.com%2Fquote%2FUTZ%2F&a=UTZ)\n\n) related to its sale to Intersnack Group GmbH & Co. KG. Under the terms\nof the proposed transaction, Utz shareholders are expected to receive $14.25\nper share in cash.\nClick here for more information https://monteverdelaw.com/case/utz-brands-inc/\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4747555-1&h=3535014368&u=https%3A%2F%2Fmonteverdelaw.com%2Fcase%2Futz-brands-inc%2F&a=https%3A%2F%2Fmonteverdelaw.com%2Fcase%2Futz-brands-inc%2F)\n. It is free and there is no cost or obligation to you.\n\n * Twin Vee PowerCats Co. (NASDAQ:\nVEEE\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4747555-1&h=1032748712&u=https%3A%2F%2Ffinance.yahoo.com%2Fquote%2FVEEE%2F&a=VEEE)\n\n) related to its merger with USFM Corporation.\nClick here for more info\nhttps://monteverdelaw.com/case/twin-vee-powercats-co-2/\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4747555-1&h=221982535&u=https%3A%2F%2Fmonteverdelaw.com%2Fcase%2Ftwin-vee-powercats-co-2%2F&a=https%3A%2F%2Fmonteverdelaw.com%2Fcase%2Ftwin-vee-powercats-co-2%2F)\n. It is free and there is no cost or obligation to you.\n\nNOT ALL LAW FIRMS ARE THE SAME. Before you hire a law firm, you should talk to\na lawyer and ask:\n\n 1. Do you file class actions and go to Court?\n 2. When was the last time you recovered money for shareholders?\n 3. What cases did you recover money in and how much?\nAbout Monteverde & Associates PC\n\nOur firm litigates and has recovered money for shareholders…and we do it\nfrom our offices in the Empire State Building. We are a national class action\nsecurities firm with a successful track record in trial and appellate courts,\nincluding the U.S. Supreme Court.\n\nNo company, director or officer is above the law. If you own common stock in\nthe above listed company and have concerns or wish to obtain additional\ninformation free of charge, please visit our website\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4747555-1&h=2500730179&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D2721435-1%26h%3D2503619756%26u%3Dhttps%253A%252F%252Fwww.monteverdelaw.com%252F%26a%3Dwebsite&a=website)\n or contact Juan Monteverde, Esq. either via e-mail at\njmonteverde@monteverdelaw.com (mailto:jmonteverde@monteverdelaw.com)  or by\ntelephone at (212) 971-1341.\n\nContact:\nJuan Monteverde, Esq.\nMONTEVERDE & ASSOCIATES PC\nThe Empire State Building\n350 Fifth Ave. Suite 4740\nNew York, NY 10118\nUnited States of America\njmonteverde@monteverdelaw.com (mailto:jmonteverde@monteverdelaw.com)\nTel: (212) 971-1341\n\nAttorney Advertising. (C) 2026 Monteverde & Associates PC. The law firm\nresponsible for this advertisement is Monteverde & Associates PC\n(www.monteverdelaw.com\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4747555-1&h=4237975150&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D2721435-1%26h%3D4276761662%26u%3Dhttp%253A%252F%252Fwww.monteverdelaw.com%252F%26a%3Dwww.monteverdelaw.com&a=www.monteverdelaw.com)\n).  Prior results do not guarantee a similar outcome with respect to any\nfuture matter.\n\nView original content to download\nmultimedia:https://www.prnewswire.com/news-releases/shareholder-alert-the-ma-class-action-firm-continues-to-investigate-the-mergercrnx-psbq-utz-and-veee-302845286.html\n(https://www.prnewswire.com/news-releases/shareholder-alert-the-ma-class-action-firm-continues-to-investigate-the-mergercrnx-psbq-utz-and-veee-302845286.html)\n\nSOURCE Monteverde & Associates PC\n\n\n\nPhoto: \nhttps://mmx.prnewswire.com/media/MS753151/Monteverde-Associates-PC-Logo.jpg?id=OA2833602\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved.","article_body_html":"","raw_payload":{"data":{"id":"nPn1JXJj1a","title":"SHAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger--CRNX, PSBQ, UTZ, and VEEE","author":"PR Newswire","ticker":"CRNX","created":"2026-08-06T20:33:00.250Z","tickers":["CRNX","PSBQ","UTZ","VEEE"],"exchange":"NASDAQ","article_body":"SHAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger--CRNX, PSBQ, UTZ, and VEEE\n\nPR Newswire\n\nNEW YORK, Aug. 6, 2026\n\nNEW YORK, Aug. 6, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4747555-1&h=2348939473&u=https%3A%2F%2Fprofiles.superlawyers.com%2Fnew-york%2Fnew-york%2Flawyer%2Fjuan-e-monteverde%2Fb861d99b-d20f-4376-92c4-2996390bacbc.html&a=Juan+Monteverde)\nwith Monteverde & Associates PC\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4747555-1&h=4135774098&u=http%3A%2F%2Fwww.monteverdelaw.com%2F&a=Monteverde+%26+Associates+PC)\n (the \"M&A Class Action Firm\"), has recovered millions of dollars for\nshareholders and is recognized as a Top 50 Firm in the 2025 ISS Securities\nClass Action Services Report. We are headquartered at the Empire State\nBuilding in New York City and are investigating\n\n * Crinetics Pharmaceuticals, Inc. (NASDAQ:\nCRNX\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4747555-1&h=2432464138&u=https%3A%2F%2Ffinance.yahoo.com%2Fquote%2FCRNX%2F&a=CRNX)\n\n) related to its sale to Vertex Pharmaceuticals Incorporated. Under the terms\nof the proposed transaction, Crinetics shareholders are expected to receive\n$85.00 per share in cash.\nACT NOW. The Shareholder Vote is scheduled for August 28, 2026.\n\nClick here for more info\nhttps://monteverdelaw.com/case/crinetics-pharmaceuticals-inc/\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4747555-1&h=738812358&u=https%3A%2F%2Fmonteverdelaw.com%2Fcase%2Fcrinetics-pharmaceuticals-inc%2F&a=https%3A%2F%2Fmonteverdelaw.com%2Fcase%2Fcrinetics-pharmaceuticals-inc%2F)\n. It is free and there is no cost or obligation to you.\n\n * PSB Holdings, Inc. (OTCQX:\nPSBQ\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4747555-1&h=1553703844&u=https%3A%2F%2Ffinance.yahoo.com%2Fquote%2FPSBQ%2F&a=PSBQ)\n\n) related to its sale to Bank First Corporation. Under the terms of the\nproposed transaction, PSB shareholders are expected to receive 0.3470 shares\nof Bank First common stock for each share of PSB.\nACT NOW. The Shareholder Vote is scheduled for September 2, 2026.\n\nClick here for more information\nhttps://monteverdelaw.com/case/psb-holdings-inc/\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4747555-1&h=3029835518&u=https%3A%2F%2Fmonteverdelaw.com%2Fcase%2Fpsb-holdings-inc%2F&a=https%3A%2F%2Fmonteverdelaw.com%2Fcase%2Fpsb-holdings-inc%2F)\n. It is free and there is no cost or obligation to you.\n\n * Utz Brands, Inc. (NYSE:\nUTZ\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4747555-1&h=609293463&u=https%3A%2F%2Ffinance.yahoo.com%2Fquote%2FUTZ%2F&a=UTZ)\n\n) related to its sale to Intersnack Group GmbH & Co. KG. Under the terms\nof the proposed transaction, Utz shareholders are expected to receive $14.25\nper share in cash.\nClick here for more information https://monteverdelaw.com/case/utz-brands-inc/\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4747555-1&h=3535014368&u=https%3A%2F%2Fmonteverdelaw.com%2Fcase%2Futz-brands-inc%2F&a=https%3A%2F%2Fmonteverdelaw.com%2Fcase%2Futz-brands-inc%2F)\n. It is free and there is no cost or obligation to you.\n\n * Twin Vee PowerCats Co. (NASDAQ:\nVEEE\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4747555-1&h=1032748712&u=https%3A%2F%2Ffinance.yahoo.com%2Fquote%2FVEEE%2F&a=VEEE)\n\n) related to its merger with USFM Corporation.\nClick here for more info\nhttps://monteverdelaw.com/case/twin-vee-powercats-co-2/\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4747555-1&h=221982535&u=https%3A%2F%2Fmonteverdelaw.com%2Fcase%2Ftwin-vee-powercats-co-2%2F&a=https%3A%2F%2Fmonteverdelaw.com%2Fcase%2Ftwin-vee-powercats-co-2%2F)\n. It is free and there is no cost or obligation to you.\n\nNOT ALL LAW FIRMS ARE THE SAME. Before you hire a law firm, you should talk to\na lawyer and ask:\n\n 1. Do you file class actions and go to Court?\n 2. When was the last time you recovered money for shareholders?\n 3. What cases did you recover money in and how much?\nAbout Monteverde & Associates PC\n\nOur firm litigates and has recovered money for shareholders…and we do it\nfrom our offices in the Empire State Building. We are a national class action\nsecurities firm with a successful track record in trial and appellate courts,\nincluding the U.S. Supreme Court.\n\nNo company, director or officer is above the law. If you own common stock in\nthe above listed company and have concerns or wish to obtain additional\ninformation free of charge, please visit our website\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4747555-1&h=2500730179&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D2721435-1%26h%3D2503619756%26u%3Dhttps%253A%252F%252Fwww.monteverdelaw.com%252F%26a%3Dwebsite&a=website)\n or contact Juan Monteverde, Esq. either via e-mail at\njmonteverde@monteverdelaw.com (mailto:jmonteverde@monteverdelaw.com)  or by\ntelephone at (212) 971-1341.\n\nContact:\nJuan Monteverde, Esq.\nMONTEVERDE & ASSOCIATES PC\nThe Empire State Building\n350 Fifth Ave. Suite 4740\nNew York, NY 10118\nUnited States of America\njmonteverde@monteverdelaw.com (mailto:jmonteverde@monteverdelaw.com)\nTel: (212) 971-1341\n\nAttorney Advertising. (C) 2026 Monteverde & Associates PC. The law firm\nresponsible for this advertisement is Monteverde & Associates PC\n(www.monteverdelaw.com\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4747555-1&h=4237975150&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D2721435-1%26h%3D4276761662%26u%3Dhttp%253A%252F%252Fwww.monteverdelaw.com%252F%26a%3Dwww.monteverdelaw.com&a=www.monteverdelaw.com)\n).  Prior results do not guarantee a similar outcome with respect to any\nfuture matter.\n\nView original content to download\nmultimedia:https://www.prnewswire.com/news-releases/shareholder-alert-the-ma-class-action-firm-continues-to-investigate-the-mergercrnx-psbq-utz-and-veee-302845286.html\n(https://www.prnewswire.com/news-releases/shareholder-alert-the-ma-class-action-firm-continues-to-investigate-the-mergercrnx-psbq-utz-and-veee-302845286.html)\n\nSOURCE Monteverde & Associates PC\n\n\n\nPhoto: \nhttps://mmx.prnewswire.com/media/MS753151/Monteverde-Associates-PC-Logo.jpg?id=OA2833602\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved."},"type":"article","timestamp":"2026-08-06T20:33:00.310298581Z","server_sent_at_ms":1786048380310},"received_at":"2026-08-06T20:33:00.363Z","source_url":"https://www.prnewswire.com/news-releases/shareholder-alert-the-ma-class-action-firm-continues-to-investigate-the-mergercrnx-psbq-utz-and-veee-302845286.html"},"analysis":{"id":"101243","press_release_id":"112243","analysis_json":{"industry":{"label":"Biotechnology","sector":"Health Care"},"redFlags":[],"eventType":"legal_litigation","narrative":"Monteverde & Associates PC announced it is investigating the proposed sale of Crinetics Pharmaceuticals (CRNX) to Vertex Pharmaceuticals at $85.00 per share in cash.\n\nThe release encourages shareholders to contact the firm prior to the scheduled vote on August 28, 2026, emphasizing that there is no cost or obligation to do so.\n\nThis is a plaintiff law-firm solicitation and does not constitute an issuer disclosure or a certified legal action.","sentiment":"neutral","agentHooks":{"shouldPost":false,"suggestedAngle":"Plaintiff-firm solicitation regarding CRNX merger -- suppress."},"keyFigures":{"customDimensions":{"acquisition_price_per_share":85}},"quotedText":"It is free and there is no cost or obligation to you.","namedEntities":{"people":[{"name":"Juan Monteverde","role":"Attorney"}],"products":[],"companies":[{"name":"Crinetics Pharmaceuticals, Inc.","ticker":"CRNX","relationship":"target"},{"name":"Vertex Pharmaceuticals Incorporated","relationship":"acquirer"},{"name":"Monteverde & Associates PC","relationship":"plaintiff law firm"},{"name":"PSB Holdings, Inc.","ticker":"PSBQ","relationship":"target"},{"name":"Bank First Corporation","relationship":"acquirer"},{"name":"Utz Brands, Inc.","ticker":"UTZ","relationship":"target"},{"name":"Intersnack Group GmbH & Co. KG","relationship":"acquirer"},{"name":"Twin Vee PowerCats Co.","ticker":"VEEE","relationship":"target"},{"name":"USFM Corporation","relationship":"acquirer"}],"dollarAmounts":[{"amount":"$85.00","context":"per share cash offer for Crinetics Pharmaceuticals"},{"amount":"$14.25","context":"per share cash offer for Utz Brands"}]},"materialImpact":{"score":1,"reasoning":"Plaintiff law-firm solicitation regarding a proposed M&A transaction. No new disclosure from the issuer, no class certification, and no settlement. Standard attorney advertising with 'no cost or obligation' language."},"tickerRelevance":{"others":[{"ticker":"PSBQ","relevance":"mentioned"},{"ticker":"UTZ","relevance":"mentioned"},{"ticker":"VEEE","relevance":"mentioned"}],"primary":"CRNX"},"globalImportance":10,"audienceRelevance":15,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"mid-cap","eventGravity":"law-firm-solicitation","issuerAuthored":false}},"event_type":"legal_litigation","event_type_secondary":null,"sentiment":"neutral","material_impact_score":1,"narrative":"Monteverde & Associates PC announced it is investigating the proposed sale of Crinetics Pharmaceuticals (CRNX) to Vertex Pharmaceuticals at $85.00 per share in cash.\n\nThe release encourages shareholders to contact the firm prior to the scheduled vote on August 28, 2026, emphasizing that there is no cost or obligation to do so.\n\nThis is a plaintiff law-firm solicitation and does not constitute an issuer disclosure or a certified legal action.","key_figures":{"customDimensions":{"acquisition_price_per_share":85}},"named_entities":{"people":[{"name":"Juan Monteverde","role":"Attorney"}],"products":[],"companies":[{"name":"Crinetics Pharmaceuticals, Inc.","ticker":"CRNX","relationship":"target"},{"name":"Vertex Pharmaceuticals Incorporated","relationship":"acquirer"},{"name":"Monteverde & Associates PC","relationship":"plaintiff law firm"},{"name":"PSB Holdings, Inc.","ticker":"PSBQ","relationship":"target"},{"name":"Bank First Corporation","relationship":"acquirer"},{"name":"Utz Brands, Inc.","ticker":"UTZ","relationship":"target"},{"name":"Intersnack Group GmbH & Co. KG","relationship":"acquirer"},{"name":"Twin Vee PowerCats Co.","ticker":"VEEE","relationship":"target"},{"name":"USFM Corporation","relationship":"acquirer"}],"dollarAmounts":[{"amount":"$85.00","context":"per share cash offer for Crinetics Pharmaceuticals"},{"amount":"$14.25","context":"per share cash offer for Utz Brands"}]},"model_name":"glm-4.7","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-08-07T08:17:18.077Z","global_importance":10,"audience_relevance":15,"importance_components":{"tickerTier":"mid-cap","eventGravity":"law-firm-solicitation","issuerAuthored":false}},"durationMs":120318,"modelName":"glm-4.7"}}